Anti-adhesive Effect and Safety of "Thermo-sensitive Adhesion Barrier (MEDICLORE)"
1 other identifier
interventional
90
1 country
1
Brief Summary
One of most important complication of thyroid surgery is adhesion. There are many anti-adhesive materials, but none of them showed significant outcomes. The investigators planned double blind prospective study of "Thermo-sensitive Adhesion Barrier (MEDICLORE)" to reveal anti-adhesive effect of MEDICLORE. The investigators will recruit total 90 patients (control group 45, experimental group 45) and compare postoperative outcomes about adhesion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jul 2017
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
August 18, 2017
CompletedFirst Posted
Study publicly available on registry
September 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 27, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedMarch 17, 2021
March 1, 2021
3.5 years
August 18, 2017
March 15, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Changes of postoperative adhesion will checked using answer of questionnaire that participants and physicians replied.
Participants will be followed from the operation to postoperative 2weeks, 3months, 6months
Study Arms (2)
Use MEDICLORE
EXPERIMENTALuse mediclore at the end of surgery
No antiadhesive product
NO INTERVENTIONuse no antiadhesive product at the end of surgery
Interventions
use MEDICLORE at the end of surgery as antiadhesive product
Eligibility Criteria
You may qualify if:
- planned to perform thyroidectomy due to thyroid nodule
- no evidence of distant metastasis or invasion to adjacent organ in thyroid cancer
- normal preoperative vocal cord movement
- normal preoperative laboratory study
You may not qualify if:
- uncontrolled hypertension, diabetes, chronic renal failure, coagulopathy
- history of keloid or hypertrophic scar
- Graves disease or hashimoto thyroiditis patients
- aspirin or anticoagulant medication within 7 days
- radiation exposure to the head and neck
- previous operation to the neck
- history of allergic reaction to drugs
- pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 110-744, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
August 18, 2017
First Posted
September 26, 2017
Study Start
July 1, 2017
Primary Completion
December 27, 2020
Study Completion
December 31, 2020
Last Updated
March 17, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share